XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.1
EPT - Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 212,778 $ 285,140
Adjustments to reconcile net income to net cash provided by operating activities:    
Straight-lined rents 529 94
Depreciation and amortization 151,287 139,733
Amortization of discount and debt financing costs, net 220 2,341
Realized and unrealized gains on marketable securities, net 91 (3,351)
Provision for credit losses (3) 47
Equity income from co-investments (13,209) (12,366)
Operating distributions from co-investments 13,709 9,080
Accrued interest from notes and other receivables (2,593) (3,953)
Gain on the sale of real estate and land (111,030) 0
Equity-based compensation 1,958 1,592
Loss on early retirement of debt 762 0
Gain on remeasurement of co-investment (330) (138,326)
Changes in operating assets and liabilities:    
Prepaid expenses, receivables, operating lease right-of-use assets, and other assets 2,996 (1,493)
Accounts payable, accrued liabilities, and operating lease liabilities 25,385 39,141
Other liabilities (1,047) (2,824)
Net cash provided by operating activities 281,503 314,855
Additions to real estate:    
Acquisitions of real estate and acquisition related capital expenditures, net of cash acquired (345,211) (355,309)
Redevelopment (12,046) (11,417)
Development acquisitions of and additions to real estate under development (7,856) (1,348)
Capital expenditures on rental properties (27,914) (26,388)
Investments in notes receivable 0 (1,059)
Collections of notes and other receivables 3,096 0
Proceeds from insurance for property losses 848 301
Proceeds from dispositions of real estate 125,997 0
Contributions to co-investments (3,934) (2,074)
Changes in refundable deposits (2,000) 0
Purchases of marketable securities (6,306) (163)
Sales and maturities of marketable securities 13 14
Non-operating distributions from co-investments 8,000 0
Net cash used in investing activities (267,313) (397,443)
Cash flows from financing activities:    
Proceeds from unsecured debt and mortgage notes 398,416 349,132
Payments on unsecured debt and mortgage notes (70,362) (761)
Proceeds from lines of credit 550,897 0
Repayments of lines of credit (688,842) 0
Additions to deferred charges (3,055) (2,692)
Payments related to debt prepayment penalties (697) 0
Net costs from issuance of common stock 0 (8)
Net proceeds from stock options exercised 6,028 962
Payments related to tax withholding for share-based compensation (519) 0
Distributions to noncontrolling interest (7,998) (7,901)
Redemption of noncontrolling interest (8,556) (279)
Common stock dividends paid (157,486) (148,329)
Net cash provided by financing activities 17,826 190,124
Net increase in unrestricted and restricted cash and cash equivalents 32,016 107,536
Unrestricted and restricted cash and cash equivalents at beginning of period 75,846 400,334
Unrestricted and restricted cash and cash equivalents at end of period 107,862 507,870
Supplemental disclosure of cash flow information:    
Cash paid for interest (net of $0.7 million and $0.1 million capitalized in 2025 and 2024, respectively) 61,250 58,241
Operating cash flows from operating leases 1,713 1,803
Supplemental disclosure of noncash investing and financing activities:    
Reclassifications to (from) redeemable noncontrolling interest from (to) additional paid in capital and noncontrolling interest 3,527 (13)
Leased assets obtained in exchange for new operating lease liabilities $ 2,727 $ 0